Global clinical nutrition market report published by Accurize Market Research forecast that the global market is expected to reach $69 billion by 2024; growing at a CAGR of 6.4% from 2017 to 2025. By geography, the Asia Pacific and North America are expected to grow at a CAGR of XX% and XX%, respectively, during the forecast period.

Request Sample:
https://www.accurizemarketresearch.com/report/clinical-nutrition-market/sample-request

The growing population of baby boomers, high birth rate & increasing number of premature births and the growing number of sufferers of receiving malnutrition treatment across the globe to drive the growth of the market
The growing population of baby boomers, high birth rates & an increasing number of premature births and the growing number of sufferers of receiving malnutrition treatment fuels the demand for the global clinical nutrition market. Moreover, increasing incidences of lifestyle-related diseases also boost the growth of the market.

Market Segmentation

The global clinical nutrition market has been bifurcated on the basis of product, and geography. The clinical nutrition market is segmented by product as infant nutrition, enteral nutrition, and parenteral nutrition. Further, the market is segmented by infant nutrition as milk-based, soy-based, organic, probiotic/prebiotic, and other infant nutrition. Moreover, the market by enteral nutrition is segmented as standard and chronically ill.
By geography, the market is segmented into North America, Europe, Asia-Pacific and Rest of the World (RoW). North America is further bifurcated in the U.S. and the Rest of North America whereas Europe segment consists of the UK, Germany, and the Rest of Europe. Asia-Pacific is segmented into China, Japan, and the Rest of Asia-Pacific while RoW is bifurcated into South America, the Middle East, and Africa.

“Infant nutrition accounted for the largest market share in the product segment", says Accurize

By product segment, Infant nutrition accounted for the largest market share in 2017 and is expected to continue its dominance during the forecast period 2017 – 2025, owing to increased premature births, increasing disposable income, high demand and acceptance of infant nutrition due to changing lifestyle in the emerging countries. Enteral nutrition accounted for the second largest market share in 2017.

“Asia-Pacific dominated the global market with the highest market share over the forecast period", says Accurize

In 2017, Asia-Pacific dominated the global clinical nutrition market with the largest market share of 40.4% and the fastest CAGR in 2017, and expected to continue the trend during the forecasted period, owing to emergent healthcare infrastructure, a growing number of chronic diseases, and rising disposable income of the people. Europe accounted for the second largest market share in 2017.

Ask for customization:
https://www.accurizemarketresearch.com/report/clinical-nutrition-market/ask-for-customization

Top players in the market

The key market players include Perrigo Company Plc., Ajinomto Co. Inc., Abbott Nutrition Inc., Hero Nutritional Inc., Nestle SA, Danone Baby, and Medical Nutrition BV, Baxter International Inc., Fresenius Kabi AG, Gentiva Health Services Inc., and Pfizer Inc., among others.